Breaking News Instant updates and real-time market news.

2020-11-29 14:09:05 CDR Cedar Realty Trust $9.15 / -50.8308 (-84.75%) 14:09 11/29/20 11/29 14:09 11/29/20 14:09	Cedar Realty Trust announces completion of 1-for-6.6 reverse stock split Cedar Realty Trust announced the completion of its previously announced 1-for-6.6 reverse stock split of its common stock. Every 6.6 issued and outstanding shares of common stock have been converted into one share of common stock, effective prior to the opening of trading of the Company's common stock on November 27, 2020. As previously announced, stockholders received cash in lieu of fractional shares. Concurrently with the reverse stock split, the company's operating partnership subsidiary, Cedar Realty Trust Partnership, effected a corresponding 1-for-6.6 reverse split of its outstanding units of limited partnership interest. Fractional units were not redeemed in connection with this reverse unit split.
CDR Cedar Realty Trust $9.15 / -50.8308 (-84.75%) 11/10/20 Compass Point Compass Point upgrades four retail REITs to Neutral after Pfizer 'game changer' 11/09/20 Compass Point Cedar Realty Trust upgraded to Neutral from Sell at Compass Point 04/03/20 B. Riley Securities Cedar Realty Trust price target lowered to $2 from $5 at B. Riley FBR 12/19/19 Baird Baird raises view on Shopping Center REITs to Outperform, upgrades RPT Realty

2020-11-29 14:09:05

CDR

Cedar Realty Trust

$9.15 / -50.8308 (-84.75%)

14:09

11/29/20

11/29

14:09

11/29/20

14:09

Cedar Realty Trust announces completion of 1-for-6.6 reverse stock split

Cedar Realty Trust announced the completion of its previously announced 1-for-6.6 reverse stock split of its common stock. Every 6.6 issued and outstanding shares of common stock have been converted into one share of common stock, effective prior to the opening of trading of the Company's common stock on November 27, 2020. As previously announced, stockholders received cash in lieu of fractional shares. Concurrently with the reverse stock split, the company's operating partnership subsidiary, Cedar Realty Trust Partnership, effected a corresponding 1-for-6.6 reverse split of its outstanding units of limited partnership interest. Fractional units were not redeemed in connection with this reverse unit split.

CDR Cedar Realty Trust

$9.15 / -50.8308 (-84.75%)

11/10/20 Compass Point: Compass Point upgrades four retail REITs to Neutral after Pfizer 'game changer'

11/09/20 Compass Point: Cedar Realty Trust upgraded to Neutral from Sell at Compass Point

04/03/20 B. Riley Securities: Cedar Realty Trust price target lowered to $2 from $5 at B. Riley FBR

12/19/19 Baird: Baird raises view on Shopping Center REITs to Outperform, upgrades RPT Realty

TODAY'S FREE FLY STORIES

Recommendations	Capstone Mining price target raised to C$3 from C$2.60 at BMO Capital » 11:09 01/20/21 01/20 11:09 01/20/21 11:09 CSFFF Capstone Mining $0.00 / + (+0.00%) BMO Capital analyst Rene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CSFFF Capstone Mining $0.00 / + (+0.00%) 11:00 Today TD Securities Capstone Mining price target raised to C$3.50 from C$3 at TD Securities 01/11/21 Scotiabank Capstone Mining price target raised to C$4 from C$3 at Scotiabank 01/08/21 Canaccord Capstone Mining price target raised to C$3.50 from C$3 at Canaccord 01/06/21 National Bank Capstone Mining price target raised to C$3.25 from C$2.10 at National Bank
On The Fly	Netflix subscriber growth, buyback potential wins over two new bulls » 11:07 01/20/21 01/20 11:07 01/20/21 11:07 NFLX Netflix $571.28 / +69.24 (+13.79%) Shares of Netflix (NFLX)… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $571.28 / +69.24 (+13.79%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $571.28 / +69.24 (+13.79%) 09:56 Today Fly Intel: Top five analyst upgrades 09:18 Today JPMorgan Netflix price target raised to $685 from $628 at JPMorgan 09:04 Today Morgan Stanley Netflix price target raised to $700 from $650 at Morgan Stanley 09:00 Today Wedbush Netflix price target raised to $340 from $235 at Wedbush NFLX Netflix $571.28 / +69.24 (+13.79%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $571.28 / +69.24 (+13.79%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $571.28 / +69.24 (+13.79%) 08:59 Today Fly Intel: Pre-market Movers 01/19/21 Fly Intel: After-Hours Movers 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 12/09/20 Disney rises as Wall Street analysts get more bullish ahead of investor day NFLX Netflix $571.28 / +69.24 (+13.79%) 09:55 Today Early notable gainers among liquid option names on January 20th 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th
Recommendations	Theratechnologies price target lowered to C$3.75 from C$4 at National Bank » 11:06 01/20/21 01/20 11:06 01/20/21 11:06 THTX Theratechnologies $2.26 / -0.005 (-0.22%) National Bank lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings THTX Theratechnologies $2.26 / -0.005 (-0.22%) 01/07/21 Theratechnologies gets Study May Proceed letters for tesamorelin, TH1902 trials 12/08/20 Theratechnologies announces preclinical in vivo findings for TH1902 11/16/20 Theratechnologies announces data from oral presentation at AASLD 11/03/20 Theratechnologies announces departure of Chief Commercial Officer Antunovic THTX Theratechnologies $2.26 / -0.005 (-0.22%) 01/07/21 Theratechnologies sees 2020 revenue $65.8M-$66.1M vs. $63.2M last year 01/07/21 Theratechnologies sees Q4 revenue $18.9M-$19.2M vs. $16.4M last year 10/15/20 Theratechnologies reports Q3 EPS (9c) vs. (2c) last year 09/21/20 Theratechnologies sees Q3 revenue $13.8M-$14.2M vs. 16.1M last year
Recommendations	CanWel Building price target raised to C$8.50 from C$7.50 at National Bank » 11:06 01/20/21 01/20 11:06 01/20/21 11:06 CWXZF CanWel Building Materials $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CWXZF CanWel Building Materials $0.00 / + (+0.00%) 01/04/21 Raymond James CanWel Building Materials price target raised to C$9 at Raymond James 12/18/20 CIBC CanWel Building Materials price target raised to C$8.25 from C$8 at CIBC 12/16/20 National Bank CanWel price target lowered to C$7.50 from C$8 at National Bank 11/10/20 CIBC CanWel Building Materials price target raised to C$8 from C$7 at CIBC
Upgrade	Healthpeak upgraded to Overweight from Equalweight at Capital One » 11:05 01/20/21 01/20 11:05 01/20/21 11:05 PEAK Healthpeak $29.67 / +0.52 (+1.78%) Capital One analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events PEAK Healthpeak $29.67 / +0.52 (+1.78%) 01/05/21 Baird Healthpeak assumed with an Outperform at Baird 12/29/20 Barclays Healthpeak price target raised to $33 from $30 at Barclays 12/15/20 Citi Healthpeak price target raised to $30 from $28 at Citi 12/14/20 KeyBanc Healthpeak downgraded to Sector Weight from Overweight at KeyBanc PEAK Healthpeak $29.67 / +0.52 (+1.78%) 11/02/20 Healthpeak reports Q3 AFFO 40c, consensus 39c 08/04/20 Healthpeak reports Q2 AFFO 40c, consensus 40c 02/10/21 Healthpeak - PEAK

Options	First Majestic Silver call volume above normal and directionally bullish » 11:05 01/20/21 01/20 11:05 01/20/21 11:05 AG First Majestic $13.36 / +0.7 (+5.53%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AG First Majestic $13.36 / +0.7 (+5.53%) 07:23 Today First Majestic plans to invest $168.4M on capital expenditures in 2021 07:22 Today First Majestic budgets $42.1M to be invested at Ermitano in 2021 07:20 Today First Majestic sees 2021 total production 20.6M-22.9M silver equivalent ounces 07:18 Today First Majestic reports 2020 silver production of 11.6M ounces AG First Majestic $13.36 / +0.7 (+5.53%) 01/11/21 National Bank First Majestic price target raised to C$20 from C$18 at National Bank 10/22/20 National Bank First Majestic price target lowered to C$18 from C$20 at National Bank 10/20/20 TD Securities First Majestic upgraded to Buy from Hold at TD Securities 09/11/20 National Bank First Majestic price target raised to C$20 from C$19 at National Bank AG First Majestic $13.36 / +0.7 (+5.53%) 11/05/20 First Majestic reports Q3 adj. EPS 12c, two est. (2c) 03/15/21 33rd Annual Roth Virtual Conference 10:00 Today First Majestic - AG AG First Majestic $13.36 / +0.7 (+5.53%) 01/19/21 First Majestic Silver call volume above normal and directionally bullish 12/21/20 First Majestic Silver call volume above normal and directionally bullish 12/16/20 First Majestic Silver call volume above normal and directionally bullish 12/15/20 First Majestic Silver call volume above normal and directionally bullish
Recommendations	Pan American Silver price target lowered to C$56 from C$60 at National Bank » 11:04 01/20/21 01/20 11:04 01/20/21 11:04 PAAS Pan American Silver $31.01 / +1.49 (+5.05%) National Bank analyst Don… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 01/19/21 Pan American Silver sees FY21 silver production up 35% from last year 11/04/20 Pan American Silver reports Q3 EPS 31c, consensus 38c 09/30/20 Pan American Silver restarts Huaron, Morococha operations in Peru 08/05/20 Pan American Silver reports mineral reserves estimate of 550M ounces of silver PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 07:43 Today Deutsche Bank Pan American Silver price target lowered to $26 from $35 at Deutsche Bank 01/13/21 Deutsche Bank Pan American Silver downgraded to Hold from Buy at Deutsche Bank 01/13/21 Deutsche Bank Pan American Silver downgraded to Hold from Buy at Deutsche Bank 01/11/21 National Bank Pan American Silver price target raised to C$60 from C$57 at National Bank PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 11/04/20 Pan American Silver reports Q3 adj. EPS 34c, consensus 38c 08/05/20 Pan American Silver reports Q2 adjusted EPS 28c, consensus 6c 02/18/21 Pan American Silver - PAAS PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 12/11/20 Pan American Silver put volume heavy and directionally bearish 10/08/20 Pan American Silver put volume heavy and directionally bearish 08/11/20 Unusually active option classes on open August 11th 08/05/20 Pan American Silver call volume above normal and directionally bullish
Recommendations	Fortuna Silver Mines price target lowered to C$13 from C$14 at National Bank » 11:03 01/20/21 01/20 11:03 01/20/21 11:03 FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 01/19/21 Fortuna Silver Mines sees FY21 gold production 178,000-202,000 ounces 01/19/21 Fortuna Silver Mines reports FY20 silver production of 7.13M ounces, up 19% 12/01/20 Fortuna Silver Mines provides update on disputed royalty at San Jose Mine 10/20/20 Fortuna Silver Mines announces first gold pour at Lindero mine FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 01/11/21 National Bank Fortuna Silver Mines price target raised to C$14 from C$11 at National Bank 11/16/20 Canaccord Fortuna Silver Mines downgraded to Hold from Buy at Canaccord 09/16/20 CIBC Fortuna Silver Mines price target raised to C$11.50 from C$10 at CIBC 09/11/20 National Bank Fortuna Silver Mines price target raised to C$11 from C$10.50 at National Bank FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 11/13/20 Fortuna Silver Mines reports Q3 EPS 7c, consensus 10c 08/13/20 Fortuna Silver Mines reports Q2 EPS (3c), consensus 11c FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 11/13/20 Fly Intel: Pre-market Movers FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 01/08/21 Fortuna Silver Mines call volume above normal and directionally bullish 10/14/20 Largest borrow rate increases among liquid names 09/04/20 Fortuna Silver Mines call volume above normal and directionally bullish 07/20/20 Fortuna Silver Mines call volume above normal and directionally bullish
Recommendations	Exchange Income price target raised to C$42 from C$40 at National Bank » 11:03 01/20/21 01/20 11:03 01/20/21 11:03 EIFZF Exchange Income $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EIFZF Exchange Income $0.00 / + (+0.00%) 11/17/20 Scotiabank Exchange Income price target raised to C$38 from C$32 at Scotiabank 11/16/20 Canaccord Exchange Income price target raised to C$41 from C$36 at Canaccord 11/16/20 RBC Capital Exchange Income price target raised to C$40 from C$36 at RBC Capital 11/16/20 National Bank Exchange Income price target raised to C$40 from C$36 at National Bank
Recommendations	Whitecap Resources price target raised to C$6 from C$2.50 at Scotiabank » 11:01 01/20/21 01/20 11:01 01/20/21 11:01 SPGYF Whitecap Resources $0.00 / + (+0.00%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SPGYF Whitecap Resources $0.00 / + (+0.00%) 01/15/21 RBC Capital Whitecap Resources price target raised to C$6.50 from C$3.50 at RBC Capital 12/16/20 CIBC Whitecap Resources price target raised to C$7 from C$6 at CIBC 12/11/20 TD Securities Whitecap Resources price target raised to C$5.50 from C$3.25 at TD Securities 12/11/20 TD Securities TORC Oil and Gas downgraded to Tender from Buy at TD Securities

Recommendations	Capstone Mining price target raised to C$3.50 from C$3 at TD Securities » 11:00 01/20/21 01/20 11:00 01/20/21 11:00 CSFFF Capstone Mining $0.00 / + (+0.00%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CSFFF Capstone Mining $0.00 / + (+0.00%) 01/11/21 Scotiabank Capstone Mining price target raised to C$4 from C$3 at Scotiabank 01/08/21 Canaccord Capstone Mining price target raised to C$3.50 from C$3 at Canaccord 01/06/21 National Bank Capstone Mining price target raised to C$3.25 from C$2.10 at National Bank 12/17/20 BMO Capital Capstone Mining upgraded to Outperform from Market Perform at BMO Capital
Conference/Events	Danimer Scientific participates in a conference call with Jefferies » 10:57 01/20/21 01/20 10:57 01/20/21 10:57 DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) Basic Materials Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) 12/29/20 Live Oak completes business combination, changes name to Danimer Scientific DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies 11:00 Today Danimer Scientific - DNMR DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) 01/07/21 Three new option listings and one option delisting on January 7th
General news	Treasury Action: Treasuries are holding modest losses » 10:55 01/20/21 01/20 10:55 01/20/21 10:55 Treasury Action:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial
Conference/Events	Danimer Scientific participates in a conference call with Jefferies » 10:52 01/20/21 01/20 10:52 01/20/21 10:52 DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) Basic Materials Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) 12/29/20 Live Oak completes business combination, changes name to Danimer Scientific DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) 01/07/21 Three new option listings and one option delisting on January 7th
Recommendations	iClick Interactive Asia price target raised to $18 from $12 at Alliance Global » 10:51 01/20/21 01/20 10:51 01/20/21 10:51 ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) 12/10/20 iClick Interactive Asia authorizes $15M share repurchase program 11/24/20 iClick Interactive Asia sees FY20 revenue $240M-$260M 11/12/20 iClick Interactive Asia to be added to MSCI China Small Cap Index 11/11/20 iClick Interactive Asia to acquire CMRS Group, terms not disclosed ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) 09/29/20 China Renaissance iClick Interactive Asia initiated with a Buy at China Renaissance 09/10/20 Alliance Global Partners iClick Interactive Asia price target raised to $12 from $10 at Alliance Global Partners 08/24/20 Roth Capital iClick Interactive Asia price target raised to $11.50 from $7.50 06/22/20 Alliance Global Partners iClick Interactive Asia price target raised to $10 from $8 at Alliance Global ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) 11/24/20 iClick Interactive Asia sees Q4 revenue $73M-$76M, consensus $74.41M 11/24/20 iClick Interactive Asia reports Q3 adjusted EPS 3c, consensus 1c 08/24/20 iClick Interactive Asia sees FY20 revenue $240M-$260M, consensus $249.16M 08/24/20 iClick Interactive Asia sees Q3 revenue $66M-$70M, consensus $68.34M 03 Sep ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) 08/24/20 Fly Intel: Pre-market Movers

Syndicate	Legato Merger Corp. opens at $10.15, IPO priced at $10 per unit » 10:50 01/20/21 01/20 10:50 01/20/21 10:50 LEGO Legato Merger Corp. $0.00 / + (+0.00%) Legato Merger Corp.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Tenax Therapeutics to host conference call » 10:46 01/20/21 01/20 10:46 01/20/21 10:46 TENX Tenax Therapeutics $2.30 / -0.08 (-3.36%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research TENX Tenax Therapeutics $2.30 / -0.08 (-3.36%) 01/19/21 Tenax Therapeutics announces 'transformative' acquisition of PH Precision Med TENX Tenax Therapeutics $2.30 / -0.08 (-3.36%) 12/29/20 H.C. Wainwright Tenax Therapeutics initiated with a Buy at H.C. Wainwright
Options	iQiyi call volume above normal and directionally bullish » 10:45 01/20/21 01/20 10:45 01/20/21 10:45 IQ iQIYI $20.29 / +0.805 (+4.13%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options IQ iQIYI $20.29 / +0.805 (+4.13%) 01/14/21 iQIYI announces 'Deer Squad' to premiere in the U.S. this month 01/07/21 iQIYI North America appoints Justin Poy Agency as media sales partner 12/31/20 iQIYI receives ISO/IEC 27701 certification 11/16/20 iQIYI falls 5% to $26.50 after Q3 results, Q4 guidance IQ iQIYI $20.29 / +0.805 (+4.13%) 01/19/21 UBS iQIYI downgraded to Neutral from Buy at UBS 01/13/21 HSBC iQIYI downgraded to Hold with 'structural risks mounting' at HSBC 01/13/21 HSBC iQIYI downgraded to Hold from Buy at HSBC 01/12/21 Morgan Stanley iQIYI downgraded to Underweight from Equal Weight at Morgan Stanley IQ iQIYI $20.29 / +0.805 (+4.13%) 11/16/20 iQIYI sees Q4 revenue $1.07B-$1.14B, consensus $1.13B 11/16/20 iQIYI reports Q3 EPS (24c), consensus (40c) 08/13/20 iQIYI sees Q3 revenue $984.1M-$1.0B, consensus $1.07B 08/13/20 iQIYI reports Q2 EPS (28c), consensus (49c) 17 Dec IQ iQIYI $20.29 / +0.805 (+4.13%) 12/02/20 House approves bill restricting Chinese firms on U.S exchanges, Bloomberg says 11/27/20 Alibaba, Tencent put talks to buy control of iQIYI on hold, Reuters reports 10/13/20 Chinese online video platforms drop Apple iPhone event, Bloomberg's Yuan reports 10/13/20 Chinese platforms cancel Apple product unveiling livestream, Bloomberg says IQ iQIYI $20.29 / +0.805 (+4.13%) 12/16/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: After-Hours Movers 11/16/20 Fly Intel: After-Hours Movers 08/18/20 Fly Intel: Pre-market Movers IQ iQIYI $20.29 / +0.805 (+4.13%) 01/08/21 iQiyi call volume above normal and directionally bullish 12/24/20 Unusually active option classes on open December 24th 12/23/20 Unusually active option classes on open December 23rd 12/02/20 iQiyi call volume above normal and directionally bullish
Hot Stocks	Fastenal reports December sales up 14.7% to $428.84M » 10:43 01/20/21 01/20 10:43 01/20/21 10:43 FAST Fastenal $48.58 / -1.84 (-3.65%) Fastenal earlier, in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FAST Fastenal $48.58 / -1.84 (-3.65%) 06:52 Today Fastenal signed 3,456 industrial vending devices during Q4 01/19/21 Fastenal raises quarterly dividend to 28c from 25c per share 11/20/20 Fastenal announces special one-time dividend of 40c per share 09/04/20 Fastenal reports August sales down 2.2% to $465.22M FAST Fastenal $48.58 / -1.84 (-3.65%) 12/31/20 William Blair Azek, Trex among Blair's top Specialty Distribution ideas for 2021 12/16/20 Deutsche Bank Fastenal downgraded to Hold from Buy at Deutsche Bank 10/15/20 Stephens Fastenal resumed with an Overweight at Stephens 10/15/20 Argus Fastenal price target raised to $52 from $43 at Argus FAST Fastenal $48.58 / -1.84 (-3.65%) 06:50 Today Fastenal reports Q4 EPS 34c, consensus 33c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/13/20 Fastenal reports Q3 EPS 38c, consensus 37c FAST Fastenal $48.58 / -1.84 (-3.65%) 10/13/20 Fly Intel: Pre-market Movers 10:00 Today Fastenal - FAST
Hot Stocks	AIM ImmunoTech tweets about being featured by WFTV on COVID-19 efforts » 10:40 01/20/21 01/20 10:40 01/20/21 10:40 AIM AIM ImmunoTech $2.17 / +0.075 (+3.58%) The official Twitter of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AIM AIM ImmunoTech $2.17 / +0.075 (+3.58%) 01/06/21 AIM ImmunoTech doses first COVID-19 chronic fatigue patient with Ampligen 12/24/20 AIM ImmunoTech announces IRB approval to enroll 'long haulers' in ampligen trial 12/24/20 AIM ImmunoTech announces AMP-511 EAP receives IRB approval for enrollment 12/21/20 AIM ImmunoTech: FDA grants Orphan Drug Designation status to Ampligen AIM AIM ImmunoTech $2.17 / +0.075 (+3.58%) 04/06/20 Maxim AIM ImmunoTech price target raised to $5 from $2 at Maxim AIM AIM ImmunoTech $2.17 / +0.075 (+3.58%) 11/13/20 AIM ImmunoTech reports Q3 EPS (8c), consensus (8c) 08/17/20 AIM ImmunoTech reports Q2 EPS (11c), consensus (10c)

Hot Stocks	Fulton Financial considering new 2021 repurchase program » 10:34 01/20/21 01/20 10:34 01/20/21 10:34 FULT Fulton Financial $38.00 / +14 (+1.00%) Comments taken from Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FULT Fulton Financial $38.00 / +14 (+1.00%) 07:02 Today Fulton Financial sees 2021 net interest income $620M-$640M 11/25/20 Fulton Financial declares special cash dividend 11/23/20 Fulton Financial acquires all outstanding stock of BenefitWorks 10/21/20 Fulton Financial: Previous 2020 guidance withdrawn due to impact from COVID-19 FULT Fulton Financial $38.00 / +14 (+1.00%) 06/17/20 Raymond James Fulton Financial upgraded to Outperform from Market Perform at Raymond James 06/01/20 Stephens Fulton Financial initiated with an Equal Weight at Stephens FULT Fulton Financial $38.00 / +14 (+1.00%) 01/19/21 Fulton Financial reports Q4 EPS 30c, consensus 31c 10/20/20 Fulton Financial reports Q3 EPS 38c, consensus 20c 07/21/20 Fulton Financial reports Q2 EPS 24c, consensus 10c FULT Fulton Financial $38.00 / +14 (+1.00%) 01/19/21 Fly Intel: After-Hours Movers 10:00 Today Fulton Financial - FULT
Conference/Events	Jefferies software/Internet analyst to hold analyst/industry conference call » 10:25 01/20/21 01/20 10:25 01/20/21 10:25 Software & Internet… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Options	Teladoc call volume above normal and directionally bullish » 10:25 01/20/21 01/20 10:25 01/20/21 10:25 TDOC Teladoc $248.27 / +15.53 (+6.67%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TDOC Teladoc $248.27 / +15.53 (+6.67%) 01/14/21 Teladoc falls -3.7% 01/14/21 Teladoc down 2% pre-market as UnitedHealth debuts virtual primary care offering 01/14/21 Teladoc issues inaugural corporate social responsibility report 01/11/21 Teladoc, DexCom announce CGM-powered insights for diabetes patients TDOC Teladoc $248.27 / +15.53 (+6.67%) 01/19/21 JPMorgan Teladoc remains top 2021 healthcare technology pick at JPMorgan 01/15/21 Benchmark SOC Telemed initiated with a Buy at Benchmark 01/12/21 BTIG Teladoc price target raised to $260 from $240 at BTIG 01/12/21 Piper Sandler Teladoc visibility improving, fundamentals attractive, says Piper Sandler TDOC Teladoc $248.27 / +15.53 (+6.67%) 10/28/20 Teladoc sees FY20 EPS $(1.36)-($1.32)., consensus ($1.40) 10/28/20 Teladoc sees Q4 EPS (36c)-(33c), consensus (35c) 10/28/20 Teladoc reports Q3 EPS (43c), consensus (32c) 10/28/20 Notable companies reporting after market close TDOC Teladoc $248.27 / +15.53 (+6.67%) 10/01/20 Insurers reduce coverage for virtual doctors' visits, WSJ reports 09/21/20 Teladoc accuses Amwell of patent infringement, STAT reports TDOC Teladoc $248.27 / +15.53 (+6.67%) 12/16/20 Teladoc slides on report of Amazon building telehealth business 10/28/20 Fly Intel: After-Hours Movers 08/05/20 Fly Intel: Pre-market Movers TDOC Teladoc $248.27 / +15.53 (+6.67%) 12/22/20 Teladoc call volume above normal and directionally bullish 12/22/20 Unusually active option classes on open December 22nd 12/21/20 Unusually active option classes on open December 21st 09/01/20 Teladoc call volume above normal and directionally bullish
Conference/Events	First Majestic to host conference call » 10:25 01/20/21 01/20 10:25 01/20/21 10:25 AG First Majestic $13.08 / +0.42 (+3.32%) Management discusses 4Q… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AG First Majestic $13.08 / +0.42 (+3.32%) 07:23 Today First Majestic plans to invest $168.4M on capital expenditures in 2021 07:22 Today First Majestic budgets $42.1M to be invested at Ermitano in 2021 07:20 Today First Majestic sees 2021 total production 20.6M-22.9M silver equivalent ounces 07:18 Today First Majestic reports 2020 silver production of 11.6M ounces AG First Majestic $13.08 / +0.42 (+3.32%) 01/11/21 National Bank First Majestic price target raised to C$20 from C$18 at National Bank 10/22/20 National Bank First Majestic price target lowered to C$18 from C$20 at National Bank 10/20/20 TD Securities First Majestic upgraded to Buy from Hold at TD Securities 09/11/20 National Bank First Majestic price target raised to C$20 from C$19 at National Bank AG First Majestic $13.08 / +0.42 (+3.32%) 11/05/20 First Majestic reports Q3 adj. EPS 12c, two est. (2c) 03/15/21 33rd Annual Roth Virtual Conference 10:00 Today First Majestic - AG AG First Majestic $13.08 / +0.42 (+3.32%) 01/19/21 First Majestic Silver call volume above normal and directionally bullish 12/21/20 First Majestic Silver call volume above normal and directionally bullish 12/16/20 First Majestic Silver call volume above normal and directionally bullish 12/15/20 First Majestic Silver call volume above normal and directionally bullish
Downgrade	TransEnterix downgraded to Neutral on valuation at Ladenburg » 10:24 01/20/21 01/20 10:24 01/20/21 10:24 TRXC TransEnterix $3.72 / +0.255 (+7.36%) Ladenburg Thalmann… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options TRXC TransEnterix $3.72 / +0.255 (+7.36%) 01/19/21 TransEnterix receives CE Mark for Intelligent Surgical Unit 12/17/20 TransEnterix's Senhance Surgical System adopted by Southern Surgical Hospital 12/16/20 TransEnterix gets approval for Senhance Surgical System in Russia Federation 10/07/20 TransEnterix's Senhance Surgical System adopted by Japan's Toshima Hospital TRXC TransEnterix $3.72 / +0.255 (+7.36%) 10:20 Today Ladenburg TransEnterix downgraded to Neutral from Buy at Ladenburg TRXC TransEnterix $3.72 / +0.255 (+7.36%) 01/06/21 TransEnterix sees FY20 revenue $3.0M-$3.2M, consensus $3.11M 01/06/21 TransEnterix sees Q4 revenue $1.1M, consensus $1.04M TRXC TransEnterix $3.72 / +0.255 (+7.36%) 12/18/20 Largest borrow rate increases among liquid names

Events

Earnings calls, analyst events, roadshows and more

Today at 12:00

Software & Internet Industry Meetings
Today at 13:00

Software & Internet Industry Meetings
Today at 14:00

Food/Agribusiness Industry Meetings
Today at 14:00

Energy Transition Industry Meetings
KMI
Today at 16:30

Kinder Morgan - KMI Conference Calls
AA
Today at 17:00

Alcoa - AA Conference Calls
HWC
Today at 17:00

Hancock Whitney - HWC Conference Calls
NVEC
Today at 17:00

NVE Corp. - NVEC Conference Calls
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
AGN ...
Tomorrow at 00:00

Aesthetics Tech Virtual Summit 2021 Conferences

Virtual Summit

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Cedar Realty Trust announces completion of 1-for-6.6 reverse stock split

TODAY'S FREE FLY STORIES

Get Full Fly Access